Literature DB >> 7006503

Effect of fermentation conditions on toxin production by Clostridium botulinum type B.

L S Siegel, J F Metzger.   

Abstract

To obtain high yields of toxin for the preparation of purified neurotoxoids, we examined the time of appearance and the quantity of toxin produced by the Bean strain of Clostridium botulinum type B under various conditions by using a fermentor system. The medium employed consisted of 2.0% casein hydrolylsate and 1.5% yeast extract plus an appropriate concentration of glucose. The maximum toxin concentration (4 x 10(5) to 5 x 10(5) mouse median lethal doses per ml) was attained within 48 h under the following fermentation conditions: an initial glucose concentration of 0.5 or 1.0%, a temperature of 35 degrees C, a nitrogen overlay at a rate of 5 liters/min, and an agitation rate of 50 rpm.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7006503      PMCID: PMC291715          DOI: 10.1128/aem.40.6.1023-1026.1980

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  8 in total

1.  STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD.

Authors:  M A FIOCK; M A CARDELLA; N F GEARINGER
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

2.  Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid.

Authors:  J T DUFF; J KLERER; R H BIBLER; D E MOORE; C GOTTFRIED; G G WRIGHT
Journal:  J Bacteriol       Date:  1957-05       Impact factor: 3.490

3.  The Isolation of Type B Botulinum Toxin.

Authors:  C Lamanna; H N Glassman
Journal:  J Bacteriol       Date:  1947-11       Impact factor: 3.490

4.  Amino Acid Analysis of the Isolated and Purified Components from Crystalline Toxin of Clostridium botulinum Type A.

Authors:  D A Boroff; H P Meloche; B R Dasgupta
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

5.  Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Isolation and characterization of Clostridium botulinum type B toxin.

Authors:  W H Beers; E Reich
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  Toxin production by Clostridium botulinum type A under various fermentation conditions.

Authors:  L S Siegel; J F Metzger
Journal:  Appl Environ Microbiol       Date:  1979-10       Impact factor: 4.792

8.  Human-derived immune globulins for the treatment of botulism.

Authors:  J F Metzger; G E Lewis
Journal:  Rev Infect Dis       Date:  1979 Jul-Aug
  8 in total
  4 in total

Review 1.  Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani.

Authors:  Michel R Popoff; Holger Brüggemann
Journal:  Toxins (Basel)       Date:  2022-05-24       Impact factor: 5.075

2.  Dependence of Clostridium botulinum gas and protease production on culture conditions.

Authors:  T J Montville
Journal:  Appl Environ Microbiol       Date:  1983-02       Impact factor: 4.792

Review 3.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

4.  Posttranslational Regulation of Botulinum Neurotoxin Production in Clostridium botulinum Hall A-hyper.

Authors:  Heather N'te Inzalaco; William H Tepp; Chase Fredrick; Marite Bradshaw; Eric A Johnson; Sabine Pellett
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.